期刊
JOURNAL OF PARKINSONS DISEASE
卷 7, 期 1, 页码 89-94出版社
IOS PRESS
DOI: 10.3233/JPD-161031
关键词
Parkinson's disease; deep brain stimulation; surveys; patient preference
资金
- Michael J. Fox Foundation for Parkinson's Research
The FDA has approved a multicenter, double-blind, Phase III, pivotal trial testing deep brain stimulation (DBS) in 280 people with very early stage Parkinson's disease (PD; IDE#G050016). In partnership with The Michael J. Fox Foundation for Parkinson's Research, we conducted a survey to investigate motivating factors, barriers, and gender differences among potentially eligible patients for participation in a trial testing DBS in early PD compared to standard medical treatment. The majority of survey respondents (72%) indicated they would consider learning more about participating. Early PD patients are therefore likely to consider enrolling in trials of invasive therapies that may slow symptom progression and help future patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据